10-Q Filing

HUMANA INC CIK: 49071 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0000049071-23-000049`
Period End Date	20230630
Filing Date	20230802
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	hum-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 76 Cash Flow Statement 92 Stockholders Equity 45 Comprehensive Income 36

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Receivables, net of allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$72.00M	USD	Point-in-time
Receivables, net of allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$70.00M	USD	Point-in-time
Preferred stock, par (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Preferred stock, par (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.06B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$16.21B	USD	Point-in-time
Investment securities	`ShortTermInvestments`	$13.88B	USD	Point-in-time
Investment securities	`ShortTermInvestments`	$15.25B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common stock, par (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.17	USD	Point-in-time
Common stock, par (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.17	USD	Point-in-time
Receivables, net of allowances of $72 in 2023 and $70 in 2022	`ReceivablesNetCurrent`	$1.43B	USD	Point-in-time
Receivables, net of allowances of $72 in 2023 and $70 in 2022	`ReceivablesNetCurrent`	$1.67B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.87B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.57B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$26.18B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	198.67M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$38.76B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	198.69M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.31B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.22B	USD	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockCommonShares`	73.69M	shares	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockCommonShares`	74.78M	shares	Point-in-time
Long-term investment securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$380.00M	USD	Point-in-time
Long-term investment securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$389.00M	USD	Point-in-time
Equity method investments	`EquityMethodInvestments`	$733.00M	USD	Point-in-time
Equity method investments	`EquityMethodInvestments`	$749.00M	USD	Point-in-time
Goodwill	`Goodwill`	$9.14B	USD	Point-in-time
Goodwill	`Goodwill`	$9.54B	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$3.73B	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$3.38B	USD	Point-in-time
Total assets	`Assets`	$43.05B	USD	Point-in-time
Total assets	`Assets`	$56.45B	USD	Point-in-time
Benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$10.30B	USD	Point-in-time
Benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$8.29B	USD	Point-in-time
Benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$9.26B	USD	Point-in-time
Benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$9.65B	USD	Point-in-time
Trade accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$5.24B	USD	Point-in-time
Trade accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$8.12B	USD	Point-in-time
Book overdraft	`BookOverdraftLiability`	$298.00M	USD	Point-in-time
Book overdraft	`BookOverdraftLiability`	$457.00M	USD	Point-in-time
Unearned revenues	`ContractWithCustomerLiabilityCurrent`	$286.00M	USD	Point-in-time
Unearned revenues	`ContractWithCustomerLiabilityCurrent`	$7.38B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$2.09B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$2.02B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.18B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$28.28B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$9.72B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$9.03B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.56B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.47B	USD	Point-in-time
Total liabilities	`Liabilities`	$39.56B	USD	Point-in-time
Total liabilities	`Liabilities`	$27.68B	USD	Point-in-time
Preferred stock, $1 par; 10,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $1 par; 10,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,690,082 shares issued at June 30, 2023 and 198,666,598 shares issued at December 31, 2022	`CommonStockValue`	$33.00M	USD	Point-in-time
Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,690,082 shares issued at June 30, 2023 and 198,666,598 shares issued at December 31, 2022	`CommonStockValue`	$33.00M	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapitalCommonStock`	$3.31B	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapitalCommonStock`	$3.25B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$27.47B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$25.49B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.23B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.30B	USD	Point-in-time
Treasury stock, at cost, 74,783,332 shares at June 30, 2023 and 73,691,955 shares at December 31, 2022	`TreasuryStockCommonValue`	$12.16B	USD	Point-in-time
Treasury stock, at cost, 74,783,332 shares at June 30, 2023 and 73,691,955 shares at December 31, 2022	`TreasuryStockCommonValue`	$12.75B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.83B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.31B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$57.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$59.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.10B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.89B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.34B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.63B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.51B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.37B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$56.45B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$43.05B	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$25.50B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$51.05B	USD	2 Qtrs
Premiums	`PremiumsEarnedNet`	$44.97B	USD	2 Qtrs
Premiums	`PremiumsEarnedNet`	$22.27B	USD	1 Quarter
Services	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.61B	USD	2 Qtrs
Services	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.35B	USD	1 Quarter
Services	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.98B	USD	2 Qtrs
Services	`RevenueFromContractWithCustomerIncludingAssessedTax`	$978.00M	USD	1 Quarter
Investment income	`InvestmentIncomeInterestAndDividend`	$467.00M	USD	2 Qtrs
Investment income	`InvestmentIncomeInterestAndDividend`	$50.00M	USD	2 Qtrs
Investment income	`InvestmentIncomeInterestAndDividend`	$274.00M	USD	1 Quarter
Investment income	`InvestmentIncomeInterestAndDividend`	$47.00M	USD	1 Quarter
Total revenues	`Revenues`	$53.49B	USD	2 Qtrs
Total revenues	`Revenues`	$26.75B	USD	1 Quarter
Total revenues	`Revenues`	$23.66B	USD	1 Quarter
Total revenues	`Revenues`	$47.63B	USD	2 Qtrs
Benefits	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$19.10B	USD	1 Quarter
Benefits	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$43.87B	USD	2 Qtrs
Benefits	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$22.01B	USD	1 Quarter
Benefits	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$38.72B	USD	2 Qtrs
Operating costs	`SellingGeneralAndAdministrativeExpense`	$3.17B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$6.09B	USD	2 Qtrs
Operating costs	`SellingGeneralAndAdministrativeExpense`	$6.06B	USD	2 Qtrs
Operating costs	`SellingGeneralAndAdministrativeExpense`	$3.11B	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortizationIncomeStatement`	$345.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortizationIncomeStatement`	$191.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortizationIncomeStatement`	$377.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortizationIncomeStatement`	$175.00M	USD	1 Quarter
Total operating expenses	`BenefitsLossesAndExpenses`	$25.31B	USD	1 Quarter
Total operating expenses	`BenefitsLossesAndExpenses`	$50.33B	USD	2 Qtrs
Total operating expenses	`BenefitsLossesAndExpenses`	$45.13B	USD	2 Qtrs
Total operating expenses	`BenefitsLossesAndExpenses`	$22.45B	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$2.50B	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$1.22B	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$1.44B	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$3.15B	USD	2 Qtrs
Interest expense	`InterestExpense`	$101.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$191.00M	USD	2 Qtrs
Interest expense	`InterestExpense`	$233.00M	USD	2 Qtrs
Interest expense	`InterestExpense`	$120.00M	USD	1 Quarter
Other expense (income), net	`OtherNonoperatingIncomeExpense`	$-46.00M	USD	2 Qtrs
Other expense (income), net	`OtherNonoperatingIncomeExpense`	$-54.00M	USD	1 Quarter
Other expense (income), net	`OtherNonoperatingIncomeExpense`	$29.00M	USD	2 Qtrs
Other expense (income), net	`OtherNonoperatingIncomeExpense`	$8.00M	USD	1 Quarter
Income before income taxes and equity in net losses	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.34B	USD	2 Qtrs
Income before income taxes and equity in net losses	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.26B	USD	1 Quarter
Income before income taxes and equity in net losses	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.12B	USD	1 Quarter
Income before income taxes and equity in net losses	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.88B	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$427.00M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$296.00M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$713.00M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$655.00M	USD	2 Qtrs
Equity in net (losses) earnings	`IncomeLossFromEquityMethodInvestments`	$2.00M	USD	1 Quarter
Equity in net (losses) earnings	`IncomeLossFromEquityMethodInvestments`	$-10.00M	USD	1 Quarter
Equity in net (losses) earnings	`IncomeLossFromEquityMethodInvestments`	$-2.00M	USD	2 Qtrs
Equity in net (losses) earnings	`IncomeLossFromEquityMethodInvestments`	$-27.00M	USD	2 Qtrs
Net income	`ProfitLoss`	$697.00M	USD	1 Quarter
Net income	`ProfitLoss`	$1.63B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.19B	USD	2 Qtrs
Net income	`ProfitLoss`	$956.00M	USD	1 Quarter
Net loss (income) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Net loss (income) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.00M	USD	2 Qtrs
Net loss (income) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.00M	USD	1 Quarter
Net loss (income) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Net income attributable to Humana	`NetIncomeLoss`	$1.63B	USD	2 Qtrs
Net income attributable to Humana	`NetIncomeLoss`	$959.00M	USD	1 Quarter
Net income attributable to Humana	`NetIncomeLoss`	$2.20B	USD	2 Qtrs
Net income attributable to Humana	`NetIncomeLoss`	$696.00M	USD	1 Quarter
Basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$5.50	USD	1 Quarter
Basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$12.83	USD	2 Qtrs
Basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$7.70	USD	1 Quarter
Basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$17.62	USD	2 Qtrs
Diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$17.54	USD	2 Qtrs
Diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$12.77	USD	2 Qtrs
Diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$7.66	USD	1 Quarter
Diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$5.48	USD	1 Quarter

Cash Flow Statement 92 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$956.00M	USD	1 Quarter
Net income	`ProfitLoss`	$2.19B	USD	2 Qtrs
Net income	`ProfitLoss`	$1.63B	USD	2 Qtrs
Net income	`ProfitLoss`	$697.00M	USD	1 Quarter
Loss on investment securities, net	`DebtAndEquitySecuritiesGainLoss`	$15.00M	USD	1 Quarter
Loss on investment securities, net	`DebtAndEquitySecuritiesGainLoss`	$-45.00M	USD	2 Qtrs
Loss on investment securities, net	`DebtAndEquitySecuritiesGainLoss`	$-137.00M	USD	2 Qtrs
Loss on investment securities, net	`DebtAndEquitySecuritiesGainLoss`	$-61.00M	USD	1 Quarter
Equity in net losses	`IncomeLossFromEquityMethodInvestments`	$-27.00M	USD	2 Qtrs
Equity in net losses	`IncomeLossFromEquityMethodInvestments`	$-2.00M	USD	2 Qtrs
Equity in net losses	`IncomeLossFromEquityMethodInvestments`	$-10.00M	USD	1 Quarter
Equity in net losses	`IncomeLossFromEquityMethodInvestments`	$2.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$93.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$89.00M	USD	2 Qtrs
Depreciation	`Depreciation`	$369.00M	USD	2 Qtrs
Depreciation	`Depreciation`	$410.00M	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$45.00M	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$34.00M	USD	2 Qtrs
Impairment on property and equipment	`TangibleAssetImpairmentCharges`	$140.00M	USD	2 Qtrs
Impairment on property and equipment	`TangibleAssetImpairmentCharges`	-	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$167.00M	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$1.73B	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$-269.00M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.14B	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$655.00M	USD	2 Qtrs
Benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$1.36B	USD	2 Qtrs
Benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$978.00M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-170.00M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-333.00M	USD	2 Qtrs
Unearned revenues	`IncreaseDecreaseInContractWithCustomerLiability`	$7.09B	USD	2 Qtrs
Unearned revenues	`IncreaseDecreaseInContractWithCustomerLiability`	$10.00M	USD	2 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$36.00M	USD	2 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$31.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.86B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.26B	USD	2 Qtrs
Acquisitions, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$189.00M	USD	2 Qtrs
Acquisitions, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$167.00M	USD	2 Qtrs
Purchases of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$574.00M	USD	2 Qtrs
Purchases of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$487.00M	USD	2 Qtrs
Purchases of investment securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$3.24B	USD	2 Qtrs
Purchases of investment securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$2.74B	USD	2 Qtrs
Proceeds from maturities of investment securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$577.00M	USD	2 Qtrs
Proceeds from maturities of investment securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$947.00M	USD	2 Qtrs
Proceeds from sales of investment securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$1.36B	USD	2 Qtrs
Proceeds from sales of investment securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$811.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.02B	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.67B	USD	2 Qtrs
Receipts from contract deposits, net	`PaymentsForProceedsFromContractDeposits`	$-3.08B	USD	2 Qtrs
Receipts from contract deposits, net	`PaymentsForProceedsFromContractDeposits`	$-3.51B	USD	2 Qtrs
Proceeds from issuance of senior notes, net	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$744.00M	USD	2 Qtrs
Proceeds from issuance of senior notes, net	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$1.22B	USD	2 Qtrs
Repayments of senior notes	`RepaymentsOfSeniorDebt`	$349.00M	USD	2 Qtrs
Repayments of senior notes	`RepaymentsOfSeniorDebt`	-	USD	2 Qtrs
Repayments from issuance of commercial paper, net	`ProceedsFromRepaymentsOfCommercialPaper`	$238.00M	USD	2 Qtrs
Repayments from issuance of commercial paper, net	`ProceedsFromRepaymentsOfCommercialPaper`	$-418.00M	USD	2 Qtrs
Repayment of term loan	`RepaymentsOfNotesPayable`	$500.00M	USD	2 Qtrs
Repayment of term loan	`RepaymentsOfNotesPayable`	-	USD	2 Qtrs
Debt issue costs	`PaymentsOfDebtIssuanceCosts`	$4.00M	USD	2 Qtrs
Debt issue costs	`PaymentsOfDebtIssuanceCosts`	$2.00M	USD	2 Qtrs
Change in book overdraft	`IncreaseDecreaseInBookOverdrafts`	$65.00M	USD	2 Qtrs
Change in book overdraft	`IncreaseDecreaseInBookOverdrafts`	$159.00M	USD	2 Qtrs
Common stock repurchases	`PaymentsForRepurchaseOfCommonStock`	$623.00M	USD	2 Qtrs
Common stock repurchases	`PaymentsForRepurchaseOfCommonStock`	$1.03B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$211.00M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$191.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-120.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-11.00M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.31B	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.23B	USD	2 Qtrs
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$11.15B	USD	2 Qtrs
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.83B	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.22B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.06B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.39B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.21B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.39B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.21B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.22B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.06B	USD	Point-in-time
Interest payments	`InterestPaidNet`	$175.00M	USD	2 Qtrs
Interest payments	`InterestPaidNet`	$171.00M	USD	2 Qtrs
Income tax payments, net	`IncomeTaxesPaidNet`	$681.00M	USD	2 Qtrs
Income tax payments, net	`IncomeTaxesPaidNet`	$373.00M	USD	2 Qtrs
Fair value of assets acquired, net of cash and cash equivalents acquired	`FairValueOfAssetsAcquired`	$346.00M	USD	2 Qtrs
Fair value of assets acquired, net of cash and cash equivalents acquired	`FairValueOfAssetsAcquired`	$190.00M	USD	2 Qtrs
Less: Fair value of liabilities assumed	`LiabilitiesAssumed1`	$162.00M	USD	2 Qtrs
Less: Fair value of liabilities assumed	`LiabilitiesAssumed1`	$23.00M	USD	2 Qtrs
Less: Noncontrolling interests acquired	`NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired`	-	USD	2 Qtrs
Less: Noncontrolling interests acquired	`NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired`	$-5.00M	USD	2 Qtrs
Cash paid for acquired businesses, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$189.00M	USD	2 Qtrs
Cash paid for acquired businesses, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$167.00M	USD	2 Qtrs

Stockholders Equity 45 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.10B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.89B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.34B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.63B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.51B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.37B	USD	Point-in-time
Net income	`ProfitLoss`	$1.63B	USD	2 Qtrs
Net income	`ProfitLoss`	$697.00M	USD	1 Quarter
Net income	`ProfitLoss`	$956.00M	USD	1 Quarter
Net income	`ProfitLoss`	$2.19B	USD	2 Qtrs
Distribution from (to) noncontrolling interest holders, net	`NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders`	$-4.00M	USD	1 Quarter
Distribution from (to) noncontrolling interest holders, net	`NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders`	$-4.00M	USD	2 Qtrs
Distribution from (to) noncontrolling interest holders, net	`NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders`	$3.00M	USD	1 Quarter
Distribution from (to) noncontrolling interest holders, net	`NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders`	$7.00M	USD	2 Qtrs
Acquisition	`MinorityInterestDecreaseFromRedemptions`	$5.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-1.09B	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-479.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-113.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$78.00M	USD	2 Qtrs
Common stock repurchases	`TreasuryStockValueAcquiredCostMethod`	$1.03B	USD	2 Qtrs
Common stock repurchases	`TreasuryStockValueAcquiredCostMethod`	$628.00M	USD	2 Qtrs
Common stock repurchases	`TreasuryStockValueAcquiredCostMethod`	$534.00M	USD	1 Quarter
Common stock repurchases	`TreasuryStockValueAcquiredCostMethod`	$4.00M	USD	1 Quarter
Dividends and dividend equivalents	`DividendsCommonStockCash`	$110.00M	USD	1 Quarter
Dividends and dividend equivalents	`DividendsCommonStockCash`	$201.00M	USD	2 Qtrs
Dividends and dividend equivalents	`DividendsCommonStockCash`	$222.00M	USD	2 Qtrs
Dividends and dividend equivalents	`DividendsCommonStockCash`	$100.00M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$93.00M	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$50.00M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$51.00M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$89.00M	USD	2 Qtrs
Restricted stock unit vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Restricted stock unit vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Restricted stock unit vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	2 Qtrs
Restricted stock unit vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	2 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$8.00M	USD	1 Quarter
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$13.00M	USD	2 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$4.00M	USD	1 Quarter
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$8.00M	USD	2 Qtrs
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.51B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.10B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.89B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.34B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.63B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.37B	USD	Point-in-time

Comprehensive Income 36 line items

Line Item	Tag	Value	Unit	Period
Net income attributable to Humana	`NetIncomeLoss`	$2.20B	USD	2 Qtrs
Net income attributable to Humana	`NetIncomeLoss`	$696.00M	USD	1 Quarter
Net income attributable to Humana	`NetIncomeLoss`	$1.63B	USD	2 Qtrs
Net income attributable to Humana	`NetIncomeLoss`	$959.00M	USD	1 Quarter
Change in gross unrealized investment gains (losses)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-1.39B	USD	2 Qtrs
Change in gross unrealized investment gains (losses)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-137.00M	USD	1 Quarter
Change in gross unrealized investment gains (losses)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-623.00M	USD	1 Quarter
Change in gross unrealized investment gains (losses)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$51.00M	USD	2 Qtrs
Effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$12.00M	USD	2 Qtrs
Effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-144.00M	USD	1 Quarter
Effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-31.00M	USD	1 Quarter
Effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-320.00M	USD	2 Qtrs
Total change in unrealized investment gains (losses), net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-479.00M	USD	1 Quarter
Total change in unrealized investment gains (losses), net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$39.00M	USD	2 Qtrs
Total change in unrealized investment gains (losses), net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-106.00M	USD	1 Quarter
Total change in unrealized investment gains (losses), net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.07B	USD	2 Qtrs
Reclassification adjustment for net realized losses (gains)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent`	$-8.00M	USD	1 Quarter
Reclassification adjustment for net realized losses (gains)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent`	$-27.00M	USD	2 Qtrs
Reclassification adjustment for net realized losses (gains)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent`	-	USD	1 Quarter
Reclassification adjustment for net realized losses (gains)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent`	$53.00M	USD	2 Qtrs
Effect of income taxes	`OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent`	$-6.00M	USD	2 Qtrs
Effect of income taxes	`OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent`	$-1.00M	USD	1 Quarter
Effect of income taxes	`OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent`	-	USD	1 Quarter
Effect of income taxes	`OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent`	$14.00M	USD	2 Qtrs
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-7.00M	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-21.00M	USD	2 Qtrs
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$39.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-479.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-113.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$78.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-1.09B	USD	2 Qtrs
Comprehensive income attributable to Humana	`ComprehensiveIncomeNetOfTax`	$846.00M	USD	1 Quarter
Comprehensive income attributable to Humana	`ComprehensiveIncomeNetOfTax`	$533.00M	USD	2 Qtrs
Comprehensive income attributable to Humana	`ComprehensiveIncomeNetOfTax`	$2.28B	USD	2 Qtrs
Comprehensive income attributable to Humana	`ComprehensiveIncomeNetOfTax`	$217.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.